This standard 96-well ELISA based assay is a game changer for evaluating convalescent plasma, antibody therapies and determining the effectiveness of vaccines for COVID-19
ImmunoRankoffers a faster, simpler, more cost effective way to identify high titer convalescent plasma for use in both treating covid-19 patients and for creating covid-19 hyperimmune globulins
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.